Cargando…

Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study

BACKGROUND: Immunoglobulin G (IgG) N-glycans have been shown to be associated with the risk of type 2 diabetes (T2D) and its risk factors. However, whether these associations reflect causal effects remain unclear. Furthermore, the associations of IgG N-glycans and inflammation are not fully understo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Biyan, Liu, Di, Song, Manshu, Wang, Wei, Guo, Bo, Wang, Youxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476573/
https://www.ncbi.nlm.nih.gov/pubmed/36104772
http://dx.doi.org/10.1186/s10020-022-00543-z
_version_ 1784790168357568512
author Wang, Biyan
Liu, Di
Song, Manshu
Wang, Wei
Guo, Bo
Wang, Youxin
author_facet Wang, Biyan
Liu, Di
Song, Manshu
Wang, Wei
Guo, Bo
Wang, Youxin
author_sort Wang, Biyan
collection PubMed
description BACKGROUND: Immunoglobulin G (IgG) N-glycans have been shown to be associated with the risk of type 2 diabetes (T2D) and its risk factors. However, whether these associations reflect causal effects remain unclear. Furthermore, the associations of IgG N-glycans and inflammation are not fully understood. METHODS: We examined the causal associations of IgG N-glycans with inflammation (C-reactive protein (CRP) and fibrinogen) and T2D using two-sample Mendelian randomization (MR) analysis in East Asian and European populations. Genetic variants from IgG N-glycan quantitative trait loci (QTL) data were used as instrumental variables. Two-sample MR was conducted for IgG N-glycans with inflammation (75,391 and 18,348 participants of CRP and fibrinogen in the East Asian population, 204,402 participants of CRP in the European population) and T2D risk (77,418 cases and 356,122 controls of East Asian ancestry, 81,412 cases and 370,832 controls of European ancestry). RESULTS: After correcting for multiple testing, in the East Asian population, genetically determined IgG N-glycans were associated with a higher risk of T2D, the odds ratios (ORs) were 1.009 for T2D per 1- standard deviation (SD) higher GP5, 95% CI = 1.003–1.015; P = 0.0019; and 1.013 for T2D per 1-SD higher GP13, 95% CI = 1.006–1.021; P = 0.0005. In the European population, genetically determined decreased GP9 was associated with T2D (OR = 0.899 per 1-SD lower GP9, 95% CI: 0.845–0.957). In addition, there was suggestive evidence that genetically determined IgG N-glycans were associated with CRP in both East Asian and European populations after correcting for multiple testing, but no associations were found between IgG N-glycans and fibrinogen. There was limited evidence of heterogeneity and pleiotropy bias. CONCLUSIONS: Our results provided novel genetic evidence that IgG N-glycans are causally associated with T2D. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-022-00543-z.
format Online
Article
Text
id pubmed-9476573
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94765732022-09-16 Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study Wang, Biyan Liu, Di Song, Manshu Wang, Wei Guo, Bo Wang, Youxin Mol Med Research Article BACKGROUND: Immunoglobulin G (IgG) N-glycans have been shown to be associated with the risk of type 2 diabetes (T2D) and its risk factors. However, whether these associations reflect causal effects remain unclear. Furthermore, the associations of IgG N-glycans and inflammation are not fully understood. METHODS: We examined the causal associations of IgG N-glycans with inflammation (C-reactive protein (CRP) and fibrinogen) and T2D using two-sample Mendelian randomization (MR) analysis in East Asian and European populations. Genetic variants from IgG N-glycan quantitative trait loci (QTL) data were used as instrumental variables. Two-sample MR was conducted for IgG N-glycans with inflammation (75,391 and 18,348 participants of CRP and fibrinogen in the East Asian population, 204,402 participants of CRP in the European population) and T2D risk (77,418 cases and 356,122 controls of East Asian ancestry, 81,412 cases and 370,832 controls of European ancestry). RESULTS: After correcting for multiple testing, in the East Asian population, genetically determined IgG N-glycans were associated with a higher risk of T2D, the odds ratios (ORs) were 1.009 for T2D per 1- standard deviation (SD) higher GP5, 95% CI = 1.003–1.015; P = 0.0019; and 1.013 for T2D per 1-SD higher GP13, 95% CI = 1.006–1.021; P = 0.0005. In the European population, genetically determined decreased GP9 was associated with T2D (OR = 0.899 per 1-SD lower GP9, 95% CI: 0.845–0.957). In addition, there was suggestive evidence that genetically determined IgG N-glycans were associated with CRP in both East Asian and European populations after correcting for multiple testing, but no associations were found between IgG N-glycans and fibrinogen. There was limited evidence of heterogeneity and pleiotropy bias. CONCLUSIONS: Our results provided novel genetic evidence that IgG N-glycans are causally associated with T2D. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-022-00543-z. BioMed Central 2022-09-14 /pmc/articles/PMC9476573/ /pubmed/36104772 http://dx.doi.org/10.1186/s10020-022-00543-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Wang, Biyan
Liu, Di
Song, Manshu
Wang, Wei
Guo, Bo
Wang, Youxin
Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study
title Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study
title_full Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study
title_fullStr Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study
title_full_unstemmed Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study
title_short Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study
title_sort immunoglobulin g n-glycan, inflammation and type 2 diabetes in east asian and european populations: a mendelian randomization study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476573/
https://www.ncbi.nlm.nih.gov/pubmed/36104772
http://dx.doi.org/10.1186/s10020-022-00543-z
work_keys_str_mv AT wangbiyan immunoglobulingnglycaninflammationandtype2diabetesineastasianandeuropeanpopulationsamendelianrandomizationstudy
AT liudi immunoglobulingnglycaninflammationandtype2diabetesineastasianandeuropeanpopulationsamendelianrandomizationstudy
AT songmanshu immunoglobulingnglycaninflammationandtype2diabetesineastasianandeuropeanpopulationsamendelianrandomizationstudy
AT wangwei immunoglobulingnglycaninflammationandtype2diabetesineastasianandeuropeanpopulationsamendelianrandomizationstudy
AT guobo immunoglobulingnglycaninflammationandtype2diabetesineastasianandeuropeanpopulationsamendelianrandomizationstudy
AT wangyouxin immunoglobulingnglycaninflammationandtype2diabetesineastasianandeuropeanpopulationsamendelianrandomizationstudy